Nonaqueous capillary electrophoresis of dextromethorphan and its metabolites.
- Published in:
- Journal of Separation Science, 2014, v. 37, n. 19, p. 2785, doi. 10.1002/jssc.201400582
- By:
- Publication type:
- Article
Works matching DE "METHYL aspartate antagonists"
Results: 93
1
2
Memantine Shows Early Promise for Binge Eating Disorder.
- Published in:
- Eating Disorders Review, 2008, v. 19, n. 6, p. 5
- Publication type:
- Article
3
Effects of dextromethorphan as add-on to sitagliptin on blood glucose and serum insulin concentrations in individuals with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blinded, multiple crossover, single-dose clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 1, p. 100, doi. 10.1111/dom.12576
- By:
- Publication type:
- Article
4
Intravenous Ketamine “Burst” for Refractory Depression in a Patient with Advanced Cancer.
- Published in:
- Journal of Palliative Medicine, 2008, v. 11, n. 9, p. 1268, doi. 10.1089/jpm.2008.9828
- By:
- Publication type:
- Article
5
Acetylcholinesterase Inhibitor and N-Methyl--Aspartic Acid Receptor Antagonist Use among Hospice Enrollees with a Primary Diagnosis of Dementia.
- Published in:
- Journal of Palliative Medicine, 2008, v. 11, n. 5, p. 738, doi. 10.1089/jpm.2007.0125
- By:
- Publication type:
- Article
6
Anti-N-methyl-D-aspartate receptor encephalitis with lung adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
7
Anti-NMDAR encephalitis preceded by dura mater lesions.
- Published in:
- 2013
- By:
- Publication type:
- Letter
8
Two cases of discontinuation syndrome following cessation of memantine.
- Published in:
- Geriatrics & Gerontology International, 2009, v. 9, n. 2, p. 203, doi. 10.1111/j.1447-0594.2009.00519.x
- By:
- Publication type:
- Article
9
Modulando Experimentalmente el Dolor por Cáncer.
- Published in:
- Informe Medico, 2008, v. 10, n. 7, p. 387
- By:
- Publication type:
- Article
10
Novelty detection and memory processes within the human hippocampus.
- Published in:
- Annals of General Psychiatry, 2008, v. 7, p. 1, doi. 10.1186/1744-859X-7-S1-S91
- By:
- Publication type:
- Article
11
Is Alzheimer's a preventable disease?
- Published in:
- Annals of General Psychiatry, 2008, v. 7, p. 1, doi. 10.1186/1744-859X-7-S1-S59
- By:
- Publication type:
- Article
12
NMDA Antagonist and Antipsychotic Actions in Cortico-subcortical Circuits.
- Published in:
- Neurotoxicity Research, 2008, v. 14, n. 2/3, p. 129, doi. 10.1007/BF03033805
- By:
- Publication type:
- Article
13
Effects of Nicotine on Sensorimotor Gating Impairment Induced by Long-Term Treatment with Neurotoxic NMDA Antagonism.
- Published in:
- Neurotoxicity Research, 2008, v. 13, n. 3/4, p. 151, doi. 10.1007/BF03033499
- By:
- Publication type:
- Article
14
The antidepressant action of 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid is mediated by phosphorylation of histone deacetylase 5.
- Published in:
- Korean Journal of Physiology & Pharmacology, 2018, v. 22, n. 2, p. 155, doi. 10.4196/kjpp.2018.22.2.155
- By:
- Publication type:
- Article
15
DEVELOPMENT AND VALIDATION OF ANALYTICAL METHODS FOR SIMULTENIOUS ESTIMATION OF DRUGS IN SOFT GELATIN CAPSULE (COUGH AND COLD PREPRATION) BY UV SPECTROSCOPY.
- Published in:
- Pharma Science Monitor, 2015, v. 6, n. 2, p. 287
- By:
- Publication type:
- Article
16
Acute administration of MK-801 in an animal model of psychosis in rats interferes with cognitively demanding forms of behavioral flexibility on a rotating arena.
- Published in:
- Frontiers in Behavioral Neuroscience, 2015, v. 9, p. 1, doi. 10.3389/fnbeh.2015.00075
- By:
- Publication type:
- Article
17
Ketamine and Addiction.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. 9, p. 61
- By:
- Publication type:
- Article
18
Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 11, p. 3645, doi. 10.3390/ijms19113645
- By:
- Publication type:
- Article
19
The witchcraft of encephalitis in Salem.
- Published in:
- 2017
- By:
- Publication type:
- Letter
20
A Cell-Based Functional Assay Using a Green Fluorescent Protein-Based Calcium Indicator dCys-GCaMP.
- Published in:
- Assay & Drug Development Technologies, 2014, v. 12, n. 6, p. 342, doi. 10.1089/adt.2014.584
- By:
- Publication type:
- Article
21
Convenient method for C-labelling of a series of ( E)-Styrylamidines as NR2B-selective NMDA receptor antagonist.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2012, v. 292, n. 1, p. 85, doi. 10.1007/s10967-011-1463-6
- By:
- Publication type:
- Article
22
A systematic review of studies investigating the acute effects of N -methyl- D -aspartate receptor antagonists on behavioural despair in normal animals suggests poor predictive validity.
- Published in:
- Brain & Neuroscience Advances, 2022, p. 1, doi. 10.1177/23982128221081645
- By:
- Publication type:
- Article
23
NMDA receptor blockage with 2-amino-5-phosphonovaleric acid improves oxidative stress after spinal cord trauma in rats.
- Published in:
- Spinal Cord, 2010, v. 48, n. 4, p. 285, doi. 10.1038/sc.2009.100
- By:
- Publication type:
- Article
24
The NMDA Receptor NR1 Subunit is Critically Involved in the Regulation of NMDA Receptor Activity by C-terminal Src kinase (Csk).
- Published in:
- Neurochemical Research, 2011, v. 36, n. 2, p. 319, doi. 10.1007/s11064-010-0330-0
- By:
- Publication type:
- Article
25
The Importance of Having Arc: Expression of the Immediate-Early Gene Arc Is Required for Hippocampus-Dependent Fear Conditioning and Blocked by NMDA Receptor Antagonism.
- Published in:
- Journal of Neuroscience, 2011, v. 31, n. 31, p. 11200, doi. 10.1523/JNEUROSCI.2211-11.2011
- By:
- Publication type:
- Article
26
Specific Sites within the Ligand-Binding Domain and Ion Channel Linkers Modulate NMDA Receptor Gating.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 35, p. 11792, doi. 10.1523/JNEUROSCI.5382-09.2010
- By:
- Publication type:
- Article
27
Beneficial Effects of the NMDA Antagonist Ketamine on Decision Processes in Visual Search.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 29, p. 9947, doi. 10.1523/JNEUROSCI.6317-09.2010
- By:
- Publication type:
- Article
28
Safety of Intratympanic Injection of AM-101 in Patients with Acute Inner Ear Tinnitus.
- Published in:
- Audiology & Neurotology, 2011, v. 16, n. 6, p. 388, doi. 10.1159/000322641
- By:
- Publication type:
- Article
29
Effects of Ketamine on Context-Processing Performance in Monkeys: A New Animal Model of Cognitive Deficits in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 11, p. 2090, doi. 10.1038/npp.2013.118
- By:
- Publication type:
- Article
30
Effects of the Nitric Oxide Synthase Inhibitor L-NAME on Recognition and Spatial Memory Deficits Produced by Different NMDA Receptor Antagonists in the Rat.
- Published in:
- Neuropsychopharmacology, 2010, v. 35, n. 12, p. 2357, doi. 10.1038/npp.2010.109
- By:
- Publication type:
- Article
31
Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
- Published in:
- Psychopharmacology, 2016, v. 233, n. 15/16, p. 2901, doi. 10.1007/s00213-016-4325-7
- By:
- Publication type:
- Article
32
Ketamine-induced brain activation in awake female nonhuman primates: a translational functional imaging model.
- Published in:
- Psychopharmacology, 2016, v. 233, n. 6, p. 961, doi. 10.1007/s00213-015-4175-8
- By:
- Publication type:
- Article
33
The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.
- Published in:
- Psychopharmacology, 2016, v. 233, n. 6, p. 1045, doi. 10.1007/s00213-015-4181-x
- By:
- Publication type:
- Article
34
Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
35
Subchronic memantine induced concurrent functional disconnectivity and altered ultra-structural tissue integrity in the rodent brain: revealed by multimodal MRI.
- Published in:
- Psychopharmacology, 2013, v. 227, n. 3, p. 479, doi. 10.1007/s00213-013-2966-3
- By:
- Publication type:
- Article
36
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.
- Published in:
- Psychopharmacology, 2012, v. 223, n. 1, p. 1, doi. 10.1007/s00213-012-2680-6
- By:
- Publication type:
- Article
37
Recreational use of dextromethorphan, "Robotripping"-A brief review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
38
Beneficial effects of co-treatment with dextromethorphan on prenatally methadoneexposed offspring.
- Published in:
- Journal of Biomedical Science, 2015, v. 22, n. 1, p. 1, doi. 10.1186/s12929-015-0126-2
- By:
- Publication type:
- Article
39
Cognitive Continuum: Areas of Controversy with Cognitive Enhancers.
- Published in:
- Psychiatric Annals, 2016, v. 46, n. 2, p. 110, doi. 10.3928/00485713-20151221-02
- By:
- Publication type:
- Article
40
Long-lasting effect of NMDA receptor antagonist memantine on ethanol-cue association and relapse.
- Published in:
- Journal of Neurochemistry, 2015, v. 135, n. 6, p. 1080, doi. 10.1111/jnc.13350
- By:
- Publication type:
- Article
41
Low-dose ethanol ameliorates amnesia induced by a brief seizure model: the role of NMDA signaling.
- Published in:
- Neurological Research, 2019, v. 41, n. 7, p. 624, doi. 10.1080/01616412.2019.1602322
- By:
- Publication type:
- Article
42
Influence of NR2B-Selective NMDA Antagonist on Lindane-Induced Seizures in Rats.
- Published in:
- Pharmacology, 2009, v. 84, n. 4, p. 234, doi. 10.1159/000238055
- By:
- Publication type:
- Article
43
Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 10, p. 2181, doi. 10.1017/S1461145713000928
- By:
- Publication type:
- Article
44
Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 10, p. 2145, doi. 10.1017/S1461145713000643
- By:
- Publication type:
- Article
45
Vulnerability to psychotogenic effects of ketamine is associated with elevated D<sub>2/3</sub>-receptor availability.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 4, p. 745, doi. 10.1017/S1461145712000764
- By:
- Publication type:
- Article
46
The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2011, v. 14, n. 9, p. 1233, doi. 10.1017/S1461145710001549
- By:
- Publication type:
- Article
47
Prenatal exposure to phencyclidine produces abnormal behaviour and NMDA receptor expression in postpubertal mice.
- Published in:
- International Journal of Neuropsychopharmacology, 2010, v. 13, n. 7, p. 877, doi. 10.1017/S1461145709990757
- By:
- Publication type:
- Article
48
The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia.
- Published in:
- International Journal of Neuropsychopharmacology, 2008, v. 11, n. 7, p. 971, doi. 10.1017/S1461145708008663
- Publication type:
- Article
49
The Neurotoxicity of Nitrous Oxide: The Facts and "Putative" Mechanisms.
- Published in:
- Brain Sciences (2076-3425), 2014, v. 4, n. 1, p. 73, doi. 10.3390/brainsci4010073
- By:
- Publication type:
- Article
50
Memantine augmentation for pediatric OCD.
- Published in:
- 2009
- Publication type:
- Case Study